43 reports of this reaction
1.2% of all ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE reports
#20 most reported adverse reaction
LOSS OF CONSCIOUSNESS is the #20 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, manufactured by The Procter & Gamble Manufacturing Company. There are 43 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE to LOSS OF CONSCIOUSNESS. This represents approximately 1.2% of all 3,480 adverse event reports for this drug.
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE has an overall safety score of 65 out of 100. Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE who experience loss of consciousness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LOSS OF CONSCIOUSNESS is a less commonly reported adverse event for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, but still significant enough to appear in the safety profile.
In addition to loss of consciousness, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE:
The following drugs have also been linked to loss of consciousness in FDA adverse event reports:
LOSS OF CONSCIOUSNESS has been reported as an adverse event in 43 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LOSS OF CONSCIOUSNESS accounts for approximately 1.2% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, making it a notable side effect.
If you experience loss of consciousness while taking ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.